These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Meglitinide analogs: new insulinotropic agents for the treatment of non-insulin dependent diabetes]. Malaisse WJ Rev Med Brux; 2003 Jun; 24(3):162-8. PubMed ID: 12891883 [TBL] [Abstract][Full Text] [Related]
5. Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues. Jijakli H; Ulusoy S; Malaisse WJ Pharmacol Res; 1996; 34(3-4):105-8. PubMed ID: 9051699 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of a new class of insulin secretagogues. Malaisse WJ Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S140-3. PubMed ID: 10522840 [TBL] [Abstract][Full Text] [Related]
7. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations. Malaisse WJ Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus. Malaisse WJ Treat Endocrinol; 2003; 2(6):401-14. PubMed ID: 15981944 [TBL] [Abstract][Full Text] [Related]
9. Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line. Ichikawa K; Yamato T; Tsuji A; Ojima K; Kusama H; Kojima M Arzneimittelforschung; 2002; 52(8):605-9. PubMed ID: 12236048 [TBL] [Abstract][Full Text] [Related]
10. New esters of succinic acid and mixed molecules formed by such esters and a meglitinide analog: study of their insulinotropic potential. Laghmich A; Ladrière L; Dannacher H; Björkling F; Malaisse WJ Pharmacol Res; 2000 May; 41(5):543-54. PubMed ID: 10753554 [TBL] [Abstract][Full Text] [Related]
11. Cellular loci of sulfonylurea actions. Lebovitz HE Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031 [TBL] [Abstract][Full Text] [Related]
12. Effects of the methyl esters of pyruvate, succinate and glutamate on the secretory response to meglitinide analogues in rat pancreatic islets. Bakkali Nadi A; Zhang TM; Malaisse WJ Pharmacol Res; 1996 Mar; 33(3):191-4. PubMed ID: 8880890 [TBL] [Abstract][Full Text] [Related]
14. Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256. Mori K; Takasaki K; Katoh Y; Yano H; Ueno K; Ichimura M; Kusaka H; Nomoto Y; Higo K; Nakanishi S Eur J Pharmacol; 2005 Dec; 528(1-3):176-82. PubMed ID: 16316644 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of insulin and somatostatin release by two meglitinide analogs. Leclercq-Meyer V; Ladrière L; Fuhlendorff J; Malaisse WJ Endocrine; 1997 Dec; 7(3):311-7. PubMed ID: 9657067 [TBL] [Abstract][Full Text] [Related]
16. Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family. Lins L; Brasseur R; Malaisse WJ Biochem Pharmacol; 1995 Nov; 50(11):1879-84. PubMed ID: 8615868 [TBL] [Abstract][Full Text] [Related]
17. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells. Ohnota H; Kobayashi M; Koizumi T; Katsuno K; Sato F; Aizawa T Biochem Pharmacol; 1995 Jan; 49(2):165-71. PubMed ID: 7840793 [TBL] [Abstract][Full Text] [Related]
18. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells. Best L; Benington S Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927 [TBL] [Abstract][Full Text] [Related]
19. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas. Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019 [TBL] [Abstract][Full Text] [Related]